New Zealand Publicly Funds HIV Protection Drug
New Zealand is about to take a pioneering approach to fighting HIV/AIDS – by publicly funding pre-exposure prophylaxis (PrEP) medication Truvada, manufactured by US biotech giant Gilead. Taking this drug daily has shown to offer…
